Profil
Robert F.
Roscigno currently works at Robert F.
Roscigno Phd Consulting LLC, as President.
Dr. Roscigno also formerly worked at United Therapeutics Corp., as Director & Senior VP-Commercial Development, Liquidia Technologies, Inc., as Senior Vice President-Product Development from 2017 to 2020, Vero Biotech LLC, as Executive Vice President-Global Clinical Affairs from 2013 to 2015, and Lung Biotechnology PBC, as President & Chief Operating Officer from 2005 to 2007.
Dr. Roscigno received his doctorate degree from Duke University and undergraduate degree from Trinity College (Connecticut).
Aktive Positionen von Robert F. Roscigno
| Unternehmen | Position | Beginn |
|---|---|---|
Robert F. Roscigno Phd Consulting LLC | Präsident | - |
Ehemalige bekannte Positionen von Robert F. Roscigno
| Unternehmen | Position | Ende |
|---|---|---|
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Corporate Officer/Principal | 01.07.2020 |
Vero Biotech, Inc.
Vero Biotech, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that focused on the design, development and commercialization of inhaled nitric oxide delivery systems | Corporate Officer/Principal | 01.09.2015 |
Lung Biotechnology PBC
Lung Biotechnology PBC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Präsident | 01.07.2007 |
| UNITED THERAPEUTICS CORPORATION | Direktor/Vorstandsmitglied | - |
Ausbildung von Robert F. Roscigno
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
United Therapeutics Corp.
United Therapeutics Corp. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes products to address the unmet medical needs of patients with chronic & life-threatening conditions | Health Technology |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Health Technology |
Vero Biotech, Inc.
Vero Biotech, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that focused on the design, development and commercialization of inhaled nitric oxide delivery systems | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trinity College (Connecticut)
Trinity College (Connecticut) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lung Biotechnology PBC
Lung Biotechnology PBC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Robert F. Roscigno Phd Consulting LLC |
















